Construction, expression and immunogenicity of a novel anti-hypertension angiotensin II vaccine based on hepatitis A virus-like particle

References

• Liu LS. Chinese guidelines for the management of hypertension. 3th ed. Beijing: Chinese center for disease control and prevention press. 2011.
   Google Scholar
• World Health Organization. Non communicable diseases. Hypertension 2011;
   Google Scholar
• Shu YH, Xiao WX. Advances in Pharmacotherapy for Hypertension. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease 2012; 20:385 - 6
   Google Scholar
• North of England Hypertension Guideline Development Group (UK).. Essential Hypertension: Managing Adult Patients In Primary Care [Internet]. National Institute for Health and Clinical Excellence: Guidance. 2004; PMID: 20945577
   PubMedGoogle Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206 - 52; http://dx.doi.org/10.1161/01.HYP.0000107251.49515.c2; PMID: 14656957
   PubMed Web of Science ®Google Scholar
• Volpe M, Savoia C, De Paolis P, Ostrowska B, Tarasi D, Rubattu S. The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease. J Am Soc Nephrol 2002; 13:Suppl 3 S173 - 8; http://dx.doi.org/10.1097/01.ASN.0000032549.36050.78; PMID: 12466309
   PubMedGoogle Scholar
• González A, López B, Díez J. Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system. Med Clin North Am 2004; 88:83 - 97; http://dx.doi.org/10.1016/S0025-7125(03)00125-1; PMID: 14871052
   PubMed Web of Science ®Google Scholar
• Krum H, Gilbert RE. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders. J Hypertens 2007; 25:25 - 35; http://dx.doi.org/10.1097/HJH.0b013e3280113950; PMID: 17143168
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet 2007; 369:1208 - 19; http://dx.doi.org/10.1016/S0140-6736(07)60242-6; PMID: 17416265
   PubMed Web of Science ®Google Scholar
• Ferrario CM. Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research. J Renin Angiotensin Aldosterone Syst 2006; 7:3 - 14; http://dx.doi.org/10.3317/jraas.2006.003; PMID: 17083068
   PubMed Web of Science ®Google Scholar
• Kusov YY, Zamjatina NA, Poleschuk VF, Michailov MI, Morace G, Eberle J, et al. Immunogenicity of a chimeric hepatitis A virus (HAV) carrying the HIV gp41 epitope 2F5. Antiviral Res 2007; 73:101 - 11; http://dx.doi.org/10.1016/j.antiviral.2006.08.003; PMID: 17014915
   PubMed Web of Science ®Google Scholar
• Beneduce F, Kusov Y, Klinger M, Gauss-Müller V, Morace G. Chimeric hepatitis A virus particles presenting a foreign epitope (HIV gp41) at their surface. Antiviral Res 2002; 55:369 - 77; http://dx.doi.org/10.1016/S0166-3542(02)00073-6; PMID: 12103436
   PubMed Web of Science ®Google Scholar
• Harmon SA, Emerson SU, Huang YK, Summers DF, Ehrenfeld E. Hepatitis A viruses with deletions in the 2A gene are infectious in cultured cells and marmosets. J Virol 1995; 69:5576 - 81; PMID: 7637003
   PubMed Web of Science ®Google Scholar
• Tissot AC, Maurer P, Nussberger J, Sabat R, Pfister T, Ignatenko S, et al. Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study. Lancet 2008; 371:821 - 7; http://dx.doi.org/10.1016/S0140-6736(08)60381-5; PMID: 18328929
   PubMed Web of Science ®Google Scholar
• Ambühl PM, Tissot AC, Fulurija A, Maurer P, Nussberger J, Sabat R, et al. A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. J Hypertens 2007; 25:63 - 72; http://dx.doi.org/10.1097/HJH.0b013e32800ff5d6; PMID: 17143175
   PubMed Web of Science ®Google Scholar
• Miller SA, Accardi JR, St Onge EL. Angiotensin II vaccine: a novel approach in the treatment of hypertension. Expert Opin Biol Ther 2008; 8:1669 - 73; http://dx.doi.org/10.1517/14712598.8.11.1669; PMID: 18847303
   PubMed Web of Science ®Google Scholar
• Xie YF, Wu RF, Wu J, Li TM, Cao RY, Liu JJ. The construction and pharmacodynamic action of a novel anti-renal hypertension DNA vaccine targeted angiotensin. Pharm Biotechnol 2008; 15:79 - 85
   Google Scholar
• Jin Q. Medical& Molecular virology. Beijing: Science Press. 2001.
   Google Scholar
• Probst C, Jecht M, Gauss-Müller V. Intrinsic signals for the assembly of hepatitis A virus particles. Role of structural proteins VP4 and 2A. J Biol Chem 1999; 274:4527 - 31; http://dx.doi.org/10.1074/jbc.274.8.4527; PMID: 9988685
   PubMed Web of Science ®Google Scholar
• Anderson DA, Ross BC. Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J Virol 1990; 64:5284 - 9; PMID: 2170672
   PubMed Web of Science ®Google Scholar
• Savard C, Laliberté-Gagné MÈ, Babin C, Bolduc M, Guérin A, Drouin K, et al. Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]. [influenza NP] Vaccine 2012; 30:2535 - 42; http://dx.doi.org/10.1016/j.vaccine.2012.01.085; PMID: 22326774
   PubMed Web of Science ®Google Scholar
• Xu L, Yang D, Chen T, Su K, Ning Q. Expression of hKCTD9 protein in insect- baculovirus expression system in vitro. J Clin Hepatol 2010; 13:249 - 52
   Google Scholar
• Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005; 23:567 - 75; http://dx.doi.org/10.1038/nbt1095; PMID: 15877075
   PubMed Web of Science ®Google Scholar
• Liu YP, Wang FH, Su ZJ, Li GH, Pang Y. Progress of studies and application on baculovirus expression vector system. J Chinese Bulletin of Entomology. 2006; 51:1 - 7; http://dx.doi.org/10.1007/s11434-006-8201-4
   Web of Science ®Google Scholar
• Jin XH, Meng ZF, Chen CG. The Comparative Study on calf serum and fetal bovine serum on Sf9 cells growth and recombinant protein expression. Chinese Journal of Pathophysiology 2006; 22:415 - 6
   Google Scholar
• Anderson DA, Ross BC. Morphogenesis of hepatitis A virus: isolation and characterization of subviral particles. J Virol 1990; 64:5284 - 9; PMID: 2170672
   PubMed Web of Science ®Google Scholar
• Bishop NE, Hugo DL, Borovec SV, Anderson DA. Rapid and efficient purification of hepatitis A virus from cell culture. J Virol Methods 1994; 47:203 - 16; http://dx.doi.org/10.1016/0166-0934(94)90078-7; PMID: 8051227
   PubMed Web of Science ®Google Scholar